The FDA will require new warnings on the diabetes drug, Invokana, after clinical trials showed the drug increases the risk of foot and leg amputations.
The FDA will allow Pfizer to remove the black box warning from its quit-smoking drug, Chantix, despite a long history of causing users mental health issues.
The government has approved the 1st major clinical trial of Ecstasy to treat people with PTSD that has not responded to traditional therapy.
An Idaho mom who gave her young daughter marijuana-infused butter to soothe her seizures lost custody of her 2 kids and faces a misdemenanor charge.
A new report suggests that too many children in foster care are unnecessarily taking psychotropic drugs, and many without adequate supervision.
The DEA has ordered drug companies to produce fewer opioids in 2017, due to the opioid addiction crisis and a decreasing demand for the drugs.
On October 12, the DEA announced it would not ban kratom, an herb used as a natural medicine. Public comment on the ban will be open until December 1.
A leading group of pediatricians warned this week that codeine should never be used in children for pain relief or as a cough suppressant.
A Connecticut toddler is carrying an antibiotic-resistant form of E. coli, making her the 4th person in the U.S. found to be harboring the superbug.
Scientists found a compound that could help them create an opioid painkiller rivaling morphine, but without the side effects and addictive properties.
A second case of a superbug resistant to last-defense antibiotics has been discovered in a patient in New York, just a month after the 1st was detected.
Two drug companies must pay $67 million to settle allegations that they deceptively marketed a cancer drug and gave doctors illegal kickbacks.
A new implant designed to help people wean off of heroin and other opioid drugs has been approved by the FDA and could be available in a month.
People who are addicted to opioids are taking dangerously high doses of anti-diarrheal meds like Imodium A-D to battle withdrawal, or to get high.
New study detailing drug shortages in ERs shows drug companies won’t produce even the most vital drugs if they can’t make a big profit from them.
New testing standards have been unveiled that are intended to make painkillers harder to abuse. Companies must also prove generics have the same properties.
As citizens suffer in China, it seems that drug prices are being slashed where it hurts – in Big Pharma’s collective wallet. Will the price gouging stop?